PANTOPRAZOLE Side Effects

7006535-X | Pruritus, Urticaria
on Sep 21, 2010 Male patient from UNITED STATES , 72 years of age, weighting 160.0 lb, was treated with Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, urticaria. Pantoprazole dosage: 1 Tab Once Daily Po.

7003964-5 | Abdominal Distension
Patient was taking Pantoprazole (View Usage). Patient had the following side effects: abdominal distension on Dec 18, 2009 from UNITED STATES Additional patient health information: Male patient , 72 years of age, weighting 200.2 lb, . Pantoprazole dosage: .

7003748-8 | Bone Density Decreased, Decreased Appetite, Weight Decreased
Adverse event was reported on Dec 21, 2009 by a Male patient taking Pantoprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED STATES , weighting 142.1 lb, After Pantoprazole was administered, patient had the following side effects: bone density decreased, decreased appetite, weight decreased. During the same period patient was treated with OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), CALCIUM (View Calcium Review and Calcium Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

7003712-9 | Abdominal Discomfort
on May 27, 2009 Female patient from UNITED STATES , weighting 94.09 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort. Pantoprazole dosage: . During the same period patient was treated with NADOLOL (View Nadolol Review and Nadolol Label ), NORVASC (View Norvasc Review and Norvasc Label ).


7003682-3 | Coeliac Disease
on Apr 27, 2009 Female patient from UNITED STATES , 78 years of age, weighting 128.1 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Pantoprazole (View Usage). Patient had the following side effects: coeliac disease. Pantoprazole dosage: . During the same period patient was treated with THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), FISH OIL, HYDROGENATED (View Fish Oil, Hydrogenated Review and Fish Oil, Hydrogenated Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), CALCIUM (View Calcium Review and Calcium Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ).

7003678-1 | Optic Ischaemic Neuropathy
Patient was taking Pantoprazole (View Usage). After Pantoprazole was administered, patient had the following side effects: optic ischaemic neuropathy on Sep 04, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 150.1 lb, was diagnosed with gastrooesophageal reflux disease and. Pantoprazole dosage: . During the same period patient was treated with OURENGEDOKUTOU (View Ourengedokutou Review and Ourengedokutou Label ).

7003676-8 | Abdominal Distension, Flatulence
Adverse event was reported on Jul 14, 2009 by a Female patient taking Pantoprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED STATES , weighting 115.1 lb, Patient experienced the following unwanted or unexpected effects: abdominal distension, flatulence. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ).

7003664-1 | Product Quality Issue
on Jun 26, 2009 Female patient from UNITED STATES , weighting 175.2 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Pantoprazole (View Usage). Patient had the following side effects: product quality issue. Pantoprazole dosage: . During the same period patient was treated with BENICAR (View Benicar Review and Benicar Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6974576-4 | Flatulence, Frequent Bowel Movements, Onychoclasis
on Oct 23, 2008 Female patient from UNITED STATES , weighting 120.1 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Pantoprazole (View Usage). After Pantoprazole was administered, patient had the following side effects: flatulence, frequent bowel movements, onychoclasis. Pantoprazole dosage: . During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FOSAMAX (View Fosamax Review and Fosamax Label ).

6974467-9 | Condition Aggravated, Gastrooesophageal Reflux Disease
Patient was taking Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, gastrooesophageal reflux disease on Oct 10, 2008 from UNITED STATES Additional patient health information: Female patient , 58 years of age, was diagnosed with gastrooesophageal reflux disease and. Pantoprazole dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIZIDE (View Olmesartan Medoxomil And Hydrochlorothizide Review and Olmesartan Medoxomil And Hydrochlorothizide Label ).

6974453-9 | Coeliac Disease
Adverse event was reported on Jul 18, 2008 by a Male patient taking Pantoprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED STATES , weighting 200.2 lb, Patient had the following side effects: coeliac disease. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6974425-4 | Dysgeusia, Sensation Of Foreign Body
on Jul 01, 2008 Female patient from UNITED STATES , 52 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with Pantoprazole (View Usage). After Pantoprazole was administered, patient had the following side effects: dysgeusia, sensation of foreign body. Pantoprazole dosage: .

6972913-8 | Adenocarcinoma
on Aug 31, 2010 Female patient from AUSTRIA , 57 years of age, weighting 132.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), immunosuppression and was treated with Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: adenocarcinoma. Pantoprazole dosage: 20 Mg On Demand. During the same period patient was treated with HUMIRA (1 Df With Interval) (View Humira Review and Humira Label ), SIMVASTATIN (40 Mg) (View Simvastatin Review and Simvastatin Label ), REMICADE (View Remicade Review and Remicade Label ), SALAZOPYRIN (500 Mg Frequency Not Specified) (View Salazopyrin Review and Salazopyrin Label ), VOLTAREN (50 Mg On Demand) (View Voltaren Review and Voltaren Label ), ARAVA (20 Mg On Demand) (View Arava Review and Arava Label ), METHOTREXATE (10 To 20 Mg Weekly) (View Methotrexate Review and Methotrexate Label ).

6968965-1 | Hallucination, Visual, Heat Rash, Leukocytosis, Rash Maculo-papular
Patient was taking Pantoprazole (View Usage). Patient had the following side effects: hallucination, visual, heat rash, leukocytosis, rash maculo-papular on Sep 03, 2010 from UNITED STATES Additional patient health information: Male patient , 85 years of age, weighting 137.0 lb, was diagnosed with gastrooesophageal reflux prophylaxis and. Pantoprazole dosage: 40 Mg Bid Iv. Patient was hospitalized.

6940378-8 | Dehydration
Adverse event was reported on Jun 18, 2010 by a Female patient taking Pantoprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease, poor peripheral circulation, cardiac disorder, hypersensitivity, chronic obstructive pulmonary disease and. Location: UNITED STATES , weighting 170.2 lb, After Pantoprazole was administered, patient had the following side effects: dehydration. During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), KLOR CON (View Klor-con Review and Klor-con Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PLAVIX (View Plavix Review and Plavix Label ), BENICAR (View Benicar Review and Benicar Label ), SINGULAIR (View Singulair Review and Singulair Label ), COMBIVENT (4 X's Day) (View Combivent Review and Combivent Label ).

6939249-2 | Clostridial Infection, Enteritis
on Aug 12, 2010 Male patient from GERMANY , 81 years of age, weighting 178.8 lb, was diagnosed with gastritis, urinary tract infection (What is urinary tract infection?) and was treated with Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: clostridial infection, enteritis. Pantoprazole dosage: . During the same period patient was treated with CEFACLOR (View Cefaclor Review and Cefaclor Label ). Patient was hospitalized.

6931351-4 | Diarrhoea
on Aug 12, 2010 Male patient from GERMANY , 81 years of age, weighting 178.8 lb, was diagnosed with gastritis, urinary tract infection (What is urinary tract infection?) and was treated with Pantoprazole (View Usage). Patient had the following side effects: diarrhoea. Pantoprazole dosage: . During the same period patient was treated with CEFACLOR (View Cefaclor Review and Cefaclor Label ). Patient was hospitalized.

6914161-3 | Abdominal Pain Upper, Alopecia, Pruritus
Patient was taking Pantoprazole (View Usage). After Pantoprazole was administered, patient had the following side effects: abdominal pain upper, alopecia, pruritus on Aug 04, 2010 from UNITED STATES Additional patient health information: Female patient , 75 years of age, weighting 161.0 lb, was diagnosed with gastrooesophageal reflux disease, hiatus hernia and. Pantoprazole dosage: 1 1 Daily Oral.

6907832-6 | Hypercalcaemia, Hyperparathyroidism, Hypokalaemia, Hypomagnesaemia
Adverse event was reported on Aug 02, 2010 by a Female patient taking Pantoprazole (View Usage) (Dosage: ) . Location: NETHERLANDS , 73 years of age, Patient experienced the following unwanted or unexpected effects: hypercalcaemia, hyperparathyroidism, hypokalaemia, hypomagnesaemia. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6847990-5 | Neutropenia
on Jul 06, 2010 Male patient from FRANCE , 60 years of age, was diagnosed with barrett's oesophagus, hiatus hernia and was treated with Pantoprazole (View Usage). Patient had the following side effects: neutropenia. Pantoprazole dosage: .

6832718-5 | Dermatitis Bullous, Oedema Peripheral, Rash Erythematous, Rash Papular, Respiration Abnormal
on Jun 30, 2010 Female patient from THAILAND , 90 years of age, was diagnosed with duodenal ulcer haemorrhage and was treated with Pantoprazole (View Usage). After Pantoprazole was administered, patient had the following side effects: dermatitis bullous, oedema peripheral, rash erythematous, rash papular, respiration abnormal. Pantoprazole dosage: . During the same period patient was treated with PREDNISOLONE (5 Mg) (View Prednisolone Review and Prednisolone Label ), NEXIUM (View Nexium Review and Nexium Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6822202-7 | Jaw Disorder, Wound Treatment
Patient was taking Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: jaw disorder, wound treatment on Jun 30, 2010 from GERMANY Additional patient health information: Female patient , 76 years of age, . Pantoprazole dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6812698-9 | Anaphylactic Shock, Circulatory Collapse
Adverse event was reported on Jun 23, 2010 by a Female patient taking Pantoprazole (View Usage) (Dosage: 40 Mg As Required) was diagnosed with reflux oesophagitis and. Location: GERMANY , 42 years of age, Patient had the following side effects: anaphylactic shock, circulatory collapse. During the same period patient was treated with AERIUS (View Aerius Review and Aerius Label ). Patient was hospitalized.

6805102-8 | Arthritis, Bronchitis, Diarrhoea, Dizziness, Eczema, Insomnia, Libido Decreased, Loss Of Consciousness, Neck Pain
on Jun 28, 2010 Male patient from UNITED STATES , weighting 205.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Pantoprazole (View Usage). After Pantoprazole was administered, patient had the following side effects: arthritis (What is arthritis?), bronchitis (What is bronchitis?), diarrhoea, dizziness (What is dizziness?), eczema (What is eczema?), insomnia, libido decreased, loss of consciousness, neck pain. Pantoprazole dosage: 1 40 Mg 1 X Day.

6801884-X | Wound Treatment
on Jun 22, 2010 Female patient from GERMANY , 76 years of age, was treated with Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: wound treatment. Pantoprazole dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6782611-1 | Anaphylactic Shock, Circulatory Collapse
Patient was taking Pantoprazole (View Usage). Patient had the following side effects: anaphylactic shock, circulatory collapse on Jun 09, 2010 from GERMANY Additional patient health information: Female patient , 42 years of age, was diagnosed with reflux oesophagitis and. Pantoprazole dosage: 40 Mg As Required. During the same period patient was treated with AERIUS (View Aerius Review and Aerius Label ). Patient was hospitalized.

6781884-9 | Thrombocytopenia
Adverse event was reported on Jun 18, 2010 by a Female patient taking Pantoprazole (View Usage) (Dosage: 40 Mg Qhs Iv) was diagnosed with gastrointestinal disorder, prophylaxis and. Location: UNITED STATES , weighting 119.5 lb, After Pantoprazole was administered, patient had the following side effects: thrombocytopenia.

6754464-9 | Clostridium Difficile Colitis
on May 26, 2010 Male patient from GERMANY , weighting 112.4 lb, was diagnosed with gastric ulcer haemorrhage, ischaemic heart disease prophylaxis, pneumonia (What is pneumonia?) and was treated with Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: clostridium difficile colitis. Pantoprazole dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CEFOTIAM HYDROCHLORIDE (View Cefotiam Hydrochloride Review and Cefotiam Hydrochloride Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

6753260-6 | Clostridium Difficile Colitis, Dry Mouth
on May 26, 2010 Male patient from GERMANY , 77 years of age, was diagnosed with gastric ulcer haemorrhage, pneumonia (What is pneumonia?), dementia (What is dementia?), peripheral arterial occlusive disease, hypertension, ischaemic heart disease prophylaxis and was treated with Pantoprazole (View Usage). Patient had the following side effects: clostridium difficile colitis, dry mouth. Pantoprazole dosage: . During the same period patient was treated with CEFOTIAM HYDROCHLORIDE (View Cefotiam Hydrochloride Review and Cefotiam Hydrochloride Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), PENTOXIFYLLINE (View Pentoxifylline Review and Pentoxifylline Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ), TRIAMPUR COMPOSITUM (View Triampur Compositum Review and Triampur Compositum Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (75 Mg, Frequency Not Specified) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6741062-6 | Dizziness, Nausea
Patient was taking Pantoprazole (View Usage). After Pantoprazole was administered, patient had the following side effects: dizziness (What is dizziness?), nausea (What is nausea?) on May 25, 2010 from UNITED STATES Additional patient health information: Female patient , 27 years of age, weighting 152.0 lb, was diagnosed with dyspepsia and. Pantoprazole dosage: 40 Mg Daily Po. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ).

6730991-5 | Clostridium Difficile Colitis, Dry Mouth
Adverse event was reported on May 07, 2010 by a Male patient taking Pantoprazole (View Usage) (Dosage: ) was diagnosed with gastric ulcer haemorrhage, pneumonia (What is pneumonia?), dementia (What is dementia?), peripheral arterial occlusive disease, hypertension, ischaemic heart disease prophylaxis and. Location: GERMANY , 77 years of age, Patient experienced the following unwanted or unexpected effects: clostridium difficile colitis, dry mouth. During the same period patient was treated with CEFOTIAM HYDROCHLORIDE (View Cefotiam Hydrochloride Review and Cefotiam Hydrochloride Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), PENTOXIFYLLINE (View Pentoxifylline Review and Pentoxifylline Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ), TRIAMPUR COMPOSITUM (View Triampur Compositum Review and Triampur Compositum Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (75 Mg, Frequency Not Specified) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6724115-8 | Clostridium Difficile Colitis
on May 07, 2010 Male patient from GERMANY , weighting 112.4 lb, was diagnosed with gastric ulcer haemorrhage, ischaemic heart disease prophylaxis, pneumonia (What is pneumonia?) and was treated with Pantoprazole (View Usage). Patient had the following side effects: clostridium difficile colitis. Pantoprazole dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CEFOTIAM HYDROCHLORIDE (View Cefotiam Hydrochloride Review and Cefotiam Hydrochloride Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

6723193-X | Contusion, Erythema, Pruritus, Skin Burning Sensation, Skin Reaction
on May 04, 2010 Male patient from GERMANY , 59 years of age, was diagnosed with dysphagia and was treated with Pantoprazole (View Usage). After Pantoprazole was administered, patient had the following side effects: contusion, erythema, pruritus, skin burning sensation, skin reaction. Pantoprazole dosage: .

6710188-5 | Cystitis, Protein-losing Gastroenteropathy, Pseudomembranous Colitis, Renal Failure Acute, Weight Decreased
Patient was taking Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis, protein-losing gastroenteropathy, pseudomembranous colitis, renal failure acute, weight decreased on Apr 23, 2010 from GERMANY Additional patient health information: Male patient , 78 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, pneumonia (What is pneumonia?), epididymitis, ischaemic heart disease prophylaxis, hypertension, oedema, chronic myeloid leukaemia, pleurisy and. Pantoprazole dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CIPRO (View Cipro Review and Cipro Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), DIGITOXIN (View Digitoxin Review and Digitoxin Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), FURORESE (View Furorese Review and Furorese Label ), GLEEVEC (View Gleevec Review and Gleevec Label ), METAMIZOLE SODIUM (View Metamizole Sodium Review and Metamizole Sodium Label ). Patient was hospitalized.

6706079-6 | Anaphylactic Reaction, Chest Discomfort, Conjunctivitis, Nausea, Oedema Peripheral, Vertigo
Adverse event was reported on Apr 22, 2010 by a Female patient taking Pantoprazole (View Usage) (Dosage: ) was diagnosed with gastritis and. Location: AUSTRIA , 33 years of age, Patient had the following side effects: anaphylactic reaction, chest discomfort, conjunctivitis, nausea (What is nausea?), oedema peripheral, vertigo. Patient was hospitalized.

6700961-1 | Abdominal Pain, Arthralgia, Chest Pain, Circulatory Collapse, Gait Disturbance, Hypocalcaemia, Hypomagnesaemia, Lethargy, Muscle Spasms
on Apr 16, 2010 Female patient from UNITED KINGDOM , 78 years of age, was diagnosed with barrett's oesophagus, gastrooesophageal reflux disease, hypertension and was treated with Pantoprazole (View Usage). After Pantoprazole was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), arthralgia, chest pain (What is chest pain?), circulatory collapse, gait disturbance, hypocalcaemia, hypomagnesaemia, lethargy, muscle spasms. Pantoprazole dosage: . During the same period patient was treated with OMEPRAZOLE (20-40 Mg Daily) (View Omeprazole Review and Omeprazole Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), LEKOVIT CA (View Lekovit Ca Review and Lekovit Ca Label ), FUROSEMIDE (20-40 Mg Daily) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6700924-6 | Hypocalcaemia, Hypomagnesaemia
on Apr 16, 2010 Female patient from UNITED KINGDOM , 72 years of age, was diagnosed with gastrooesophageal reflux disease, gravitational oedema and was treated with Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: hypocalcaemia, hypomagnesaemia. Pantoprazole dosage: . During the same period patient was treated with MAGNESIUM (View Magnesium Review and Magnesium Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ). Patient was hospitalized.

6700909-X | Fatigue, Grand Mal Convulsion, Hypocalcaemia, Hypomagnesaemia, Laryngeal Oedema, Pulmonary Oedema
Patient was taking Pantoprazole (View Usage). Patient had the following side effects: fatigue, grand mal convulsion, hypocalcaemia, hypomagnesaemia, laryngeal oedema, pulmonary oedema on Apr 16, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 75 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, hypomagnesaemia, hypertension and. Pantoprazole dosage: . During the same period patient was treated with MAGNESIUM (View Magnesium Review and Magnesium Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ). Patient was hospitalized.

6700907-6 | Hypocalcaemia, Hypomagnesaemia
Adverse event was reported on Apr 16, 2010 by a Female patient taking Pantoprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED KINGDOM , 53 years of age, After Pantoprazole was administered, patient had the following side effects: hypocalcaemia, hypomagnesaemia. During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6700906-4 | Hypocalcaemia, Hypomagnesaemia
on Apr 16, 2010 Female patient from UNITED KINGDOM , 69 years of age, was diagnosed with gastrooesophageal reflux disease, hypomagnesaemia, dyspepsia, hypertension and was treated with Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: hypocalcaemia, hypomagnesaemia. Pantoprazole dosage: . During the same period patient was treated with MAGNESIUM (View Magnesium Review and Magnesium Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ).

6700905-2 | Dyspepsia, Hypocalcaemia, Hypomagnesaemia
on Apr 16, 2010 Female patient from UNITED KINGDOM , 57 years of age, was diagnosed with gastrooesophageal reflux disease, hypomagnesaemia, hypertension and was treated with Pantoprazole (View Usage). Patient had the following side effects: dyspepsia, hypocalcaemia, hypomagnesaemia. Pantoprazole dosage: . During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ). Patient was hospitalized.

6685027-1 | Condition Aggravated, Coronary Artery Disease, Coronary Artery Occlusion, Coronary Artery Stenosis, Diabetes Mellitus
Patient was taking Pantoprazole (View Usage). After Pantoprazole was administered, patient had the following side effects: condition aggravated, coronary artery disease (What is coronary artery disease?), coronary artery occlusion, coronary artery stenosis, diabetes mellitus on Apr 05, 2010 from GERMANY Additional patient health information: Female patient , weighting 180.8 lb, . Pantoprazole dosage: . During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), RASILEZ (View Rasilez Review and Rasilez Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6684951-3 | Anaphylactic Reaction, Chest Discomfort, Conjunctivitis, Nausea, Oedema Peripheral, Vertigo
Adverse event was reported on Apr 06, 2010 by a Female patient taking Pantoprazole (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: GERMANY , 33 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, chest discomfort, conjunctivitis, nausea (What is nausea?), oedema peripheral, vertigo. Patient was hospitalized.

6683385-5 | Gamma-glutamyltransferase Increased, Transaminases Increased, Tremor
on Apr 06, 2010 Male patient from GERMANY , 48 years of age, weighting 163.1 lb, was diagnosed with abdominal pain upper, prophylaxis, nausea (What is nausea?), neuralgia, intervertebral disc protrusion and was treated with Pantoprazole (View Usage). Patient had the following side effects: gamma-glutamyltransferase increased, transaminases increased, tremor. Pantoprazole dosage: . During the same period patient was treated with METOCLOPRAMIDE HYDROCHLORIDE (4 Mg) (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), FORTECORTIN (4 Mg) (View Fortecortin Review and Fortecortin Label ).

6680740-4 | Diarrhoea
on Apr 13, 2010 Male patient from UNITED STATES , weighting 194.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Pantoprazole (View Usage). After Pantoprazole was administered, patient had the following side effects: diarrhoea. Pantoprazole dosage: 40 Mg Qd Po.

6674223-5 | Intestinal Obstruction, Nausea
Patient was taking Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal obstruction, nausea (What is nausea?) on Mar 30, 2010 from UNITED STATES Additional patient health information: Female patient , 80 years of age, . Pantoprazole dosage: . Patient was hospitalized.

6665603-2 | Condition Aggravated, Coronary Artery Disease, Coronary Artery Occlusion, Coronary Artery Stenosis, Diabetes Mellitus
Adverse event was reported on Mar 22, 2010 by a Female patient taking Pantoprazole (View Usage) (Dosage: ) . Location: GERMANY , weighting 180.8 lb, Patient had the following side effects: condition aggravated, coronary artery disease (What is coronary artery disease?), coronary artery occlusion, coronary artery stenosis, diabetes mellitus. During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), RASILEZ (View Rasilez Review and Rasilez Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized and became disabled.

6650070-5 | Condition Aggravated, Gastrooesophageal Reflux Disease, Melaena, Oesophagitis
on Mar 19, 2010 Female patient from AUSTRIA , 78 years of age, was diagnosed with gastrooesophageal reflux disease, oesophagitis, pneumonia (What is pneumonia?) and was treated with Pantoprazole (View Usage). After Pantoprazole was administered, patient had the following side effects: condition aggravated, gastrooesophageal reflux disease, melaena, oesophagitis. Pantoprazole dosage: . During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), OPTINEM (1500 Mg Ampules) (View Optinem Review and Optinem Label ).

6621671-5 | Circulatory Collapse, Gait Disturbance, Hypocalcaemia, Hypomagnesaemia, Lethargy, Muscle Spasms, Paraesthesia, Tetany
on Feb 25, 2010 Female patient from UNITED KINGDOM , 78 years of age, was diagnosed with barrett's oesophagus and was treated with Pantoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse, gait disturbance, hypocalcaemia, hypomagnesaemia, lethargy, muscle spasms, paraesthesia, tetany. Pantoprazole dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALFACALCIDOL (250 Nangm Daily) (View Alfacalcidol Review and Alfacalcidol Label ), LEKOVIT CA (View Lekovit Ca Review and Lekovit Ca Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ). Patient was hospitalized.

6614546-9 | Oral Mucosal Exfoliation, Tongue Ulceration
Patient was taking Pantoprazole (View Usage). Patient had the following side effects: oral mucosal exfoliation, tongue ulceration on Mar 04, 2010 from UNITED STATES Additional patient health information: Male patient , 82 years of age, weighting 173.0 lb, was diagnosed with gastrooesophageal reflux disease and. Pantoprazole dosage: 1 Tablet Daily Mouth.